Castration-Resistant Prostate Cancer: Optimizing Interdisciplinary Collaboration in an Evolving Management Environment – Canadian Council On Continuing Education In Pharmacy (CCCEP)

By the end of this course, the learner will be able to:

1. Identify patients with castration-resistant prostate cancer (CRPC)
2. Describe the different agents used to treat CRPC
3. Understand the importance of involving a multidisciplinary healthcare team in the care of patients with CRPC
4. Recommend appropriate therapeutic choices based on the patient profile and treatment history